Recent Posts

Novel Therapeutic Agent for Pediatric Cancer Developed at UC San Diego in Clinical Trials

Donald L. Durden, MD, PhD, pediatric researcher at University of California, San Diego School of Medicine and Moores Cancer Center has identified and developed a novel therapeutic target for neuroblastoma, the second most common solid-tumor childhood cancer.

Read more here: http://health.ucsd.edu/news/releases/Pages/2015-08-11-therapeutic-target-for-pediatric-cancer-devleoped-at-uc-san-diego.aspx

Archive
Search By Tags